Warning letter
NatureMost of New England, Inc.: warning letter of May 24, 2012
FDA warning letter 240654 · New England District Office
Key facts
| Reference number | 240654 |
|---|---|
| Company | NatureMost of New England, Inc. |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | May 24, 2012 |
| Posted date | May 24, 2012 |
| Issuing office | New England District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.605, 111, 111.15, 111.15(a)(1), 111.70(b), 111.70(e), 111.155(a), 111.155(b), 111.255(b), 111.260(c), 111.260(k), 111.260(m) and 7 more |
| Inspection city | Middletown |
| Inspection ZIP | 06457 |
| Inspection start date | Sep 22, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: